Exact Sciences Corp at Canaccord Genuity Growth Conference Transcript
We're going to get started. It's 9:00. Very pleased to welcome back Exact Sciences. Many of you know Exact and have seen their commercials. They sell Cologuard. It's a tremendous noninvasive colon cancer screening test. The company has really been a spectacular stock. They've been one of our top picks for the last 3 consecutive years. The returns have been outstanding. Exact remains a top pick, and they just came off a very strong Q2. They also came off a surprising announcing to acquire Genomic Health, which was just last week. So I'm really pleased to welcome back Exact's CFO, Jeff Elliott.
Thanks, Jeff, for being here.
Thanks, Mark. It's good to be back.
Questions & Answers
All right. So why don't we start with the Genomic Health acquisition? You named a long list of reasons to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |